*|MC_PREVIEW_TEXT|*

THE FOURTH ONE-DAY INTERNATIONAL SUMMIT on Innovation, Clinical Benefits & Cost Featuring Round Table Discussions with Expert Panelists hosted by Moderators Designed to Cultivate Solutions that help Patients, Researchers, and Clinicians

REGISTER NOW WATCH CCX HIGHLIGHTS

Meet the Speakers/Panelists

Alexander Eggermont MD, PhD, Director General, Gustave Roussy, France; Chairman, Cancer Core Europe MACE ROTHENBERG MD, Chief Medical Officer, Pfizer, Pfizer, Inc MAUREEN SULLIVAN Chief Strategy and Innovation Officer, Blue Cross Blue Shield Association CLIFFORD HUDIS MD, Chief Executive Officer, American Society of Clinical Oncology (ASCO)

Kevin P. Conlin Chairman, President and CEO, Horizon Blue Cross Blue Shield of New Jersey James Gulley MD, PhD, Chief, GU Malignancies Branch; Director, Medical Oncology Services, Center for Cancer Research, NCI, NIH Jeffrey Le Benger MD, Chairman of the Board and Chief Executive Officer, Summit Medical Group and Summit Health Management MICHEL SADELAIN MD, PhD, Director, Center for Cell Engineering, Memorial Sloan Kettering Cancer Center

Cary Gross MD, Professor of Medicine and Epidemiology and Director, National Clinician Scholars Program, Yale University School of Medicine Grace Graham Health Policy Director, Senate HELP Committee – Chairman, Senator Lamar Alexander Richard Sullivan MD, PhD, Director, Institute for Cancer Policy; Professor of Cancer and Global Health, King’s College London Richard Barakat MD, Physician-in-Chief and Director of Cancer, Northwell Cancer Institute, SVP Cancer Service Line, Northwell Health

Eric Rubin MD, Senior Vice President, Global Clinical Oncology, Merck Alan Bryce MD, Chair, Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic Arizona Diane Meier MD, Director, Center to Advance Palliative Care, Mount Sinai Health System, NYC Neal Meropol MD, Vice President, Research Oncology, Flatiron Health

Andrea Califano PhD, Chair, Columbia Department of Systems Biology; Director, Sulzberger Columbia Genome Center; Associate Director, Herbert Irving Comprehensive Cancer Center Anil Rustgi MD, Director, Herbert Irving Comprehensive Cancer Center, Columbia University Rajiv Panikkar MD, Chair, Cancer Institute, Geisinger Michael Kupferman MD, MBA, SVP, Clinical and Academic Network Development and Professor, Head and Neck Surgery, UT MD Anderson Cancer Center

Razelle Kurzrock MD, PhD, Chief, Division of Hematology/Oncology, UCSD School of Medicine; Sr. Deputy Director; Director, Center for Personalized Cancer Therapy; Director, Clinical Trials Office, UCSD Moores Cancer Center Andy Schmeltz Global President and General Manager, Pfizer Oncology, Pfizer Innovative Health Glen Stettin MD, Senior Vice President and Chief Innovation Officer, Express Scripts Louis Potters MD, Deputy Physician-in-Chief, Northwell Health Cancer Institute; Professor and Chair, Department of Radiation Medicine, Zucker School of Medicine at Hofstra/Northwell

Steven Peskin MD, MBA, Executive Medical Director, Population Health, Horizon Blue Cross Blue Shield of New Jersey Mike Meyer President, Meyer Consulting Jacque Sokolov MD, Chairman and CEO, SSB Solutions

Meet the Sponsors

What You Will Learn • The latest developments in cancer care research, clinical care, and cost/pricing through the lens of health plans, academic cancer centers, pharma, and providers/oncology groups and what has happened over the last 12 months. • New innovations and technology to improve diagnosis, patient-centered and integrated care, survivorship programs and palliative care. • The future of cancer treatment and the challenges and opportunities around genomically-driven decision making. • New partnerships being formed to facilitate innovation. • The use of large data and analytics to improve outcomes and reduce cost. • The challenges facing health plans, providers and governments in financing new innovative cancer treatments in a changing health policy environment. • How genomics, precision medicine, immunotherapeutic and biosimilar therapies will change the future of cancer care. • The realities and challenges of innovative new cancer modalities like CAR T-Cell Therapy. • The impact of these new innovations on patients and families and how they are being reported in the media. • What's getting in our way of moving forward in these areas.

About the Organizer Meyer Consulting is an international health care consulting and recruiting firm which brings leading experts together in collaborative settings to build better health care solutions. www.meyerconsultinginc.com

About the Venue The New York Genome Center is a consortium of renowned academic, medical and industry leaders focusing on conducting and translating genomic research. www.nygenome.org 101 Avenue of the Americas, New York, NY NoMo SoHo Hotel For our perfered pricing at the NoMo SoHo Hotel, please click here